← FDA Drug Approvals (Drugs@FDA)

DOXYCYCLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2025-01-27

Drug application

FDA Application #

ANDA217098

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXYCYCLINE

Generic name

DOXYCYCLINE

Active ingredients

DOXYCYCLINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

PRINSTON INC

Manufacturer

Solco Healthcare US,LLC

First approval

2025-01-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown